tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ELVN Stock Latest News

Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML
Press ReleasesEnliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML
1d ago
ELVN
Enliven initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Enliven initiated with a Buy at H.C. Wainwright
11d ago
ELVN
Enliven price target raised to $39 from $34 at Mizuho
PremiumThe Fly
Enliven price target raised to $39 from $34 at Mizuho
1M ago
ELVN
Enliven reports Q2 EPS (41c), consensus (55c)
PremiumThe Fly
Enliven reports Q2 EPS (41c), consensus (55c)
1M ago
ELVN
Enliven initiated with an Outperform at Baird
PremiumThe Fly
Enliven initiated with an Outperform at Baird
3M ago
ELVN
Short Report: GameStop, AMC Entertainment bears retreat further
PremiumThe FlyShort Report: GameStop, AMC Entertainment bears retreat further
4M ago
GME
SMR
Enliven reports Q1 EPS (54c), consensus (57c)
Premium
The Fly
Enliven reports Q1 EPS (54c), consensus (57c)
4M ago
ELVN
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
Premium
Press Releases
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
4M ago
ELVN
Enliven files to sell 6.43M shares of common stock for holders
PremiumThe Fly
Enliven files to sell 6.43M shares of common stock for holders
5M ago
ELVN
Short Report: Bears reduce exposure to Kohl’s as stock momentum fizzles
PremiumThe Fly
Short Report: Bears reduce exposure to Kohl’s as stock momentum fizzles
5M ago
KSS
ELVN
Enliven announces proof of concept data from Phase 1 trial of ELVN-001
PremiumThe Fly
Enliven announces proof of concept data from Phase 1 trial of ELVN-001
5M ago
ELVN
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
PremiumPress Releases
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
5M ago
ELVN
Enliven to hold a conference call
PremiumThe FlyEnliven to hold a conference call
5M ago
ELVN
Enliven to hold a conference call
Premium
The Fly
Enliven to hold a conference call
5M ago
ELVN
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Premium
Press Releases
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
5M ago
ELVN
Enliven to hold a conference call
PremiumThe Fly
Enliven to hold a conference call
5M ago
ELVN
Enliven initiated with a Buy at Mizuho
PremiumThe Fly
Enliven initiated with a Buy at Mizuho
5M ago
ELVN
Enliven to share initial proof of concept data from ELVN-001 Phase 1 trial
PremiumThe Fly
Enliven to share initial proof of concept data from ELVN-001 Phase 1 trial
6M ago
ELVN
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024
PremiumPress Releases
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024
6M ago
ELVN
Enliven Therapeutics Secures $90M for Clinical Research Expansion
PremiumCompany AnnouncementsEnliven Therapeutics Secures $90M for Clinical Research Expansion
6M ago
8K
ELVN
Enliven announces pipeline updates
Premium
The Fly
Enliven announces pipeline updates
6M ago
ELVN
Enliven announces $90M private placement financing
Premium
The Fly
Enliven announces $90M private placement financing
6M ago
ELVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >